Liminal BioSciences Inc. ("Liminal BioSciences" or the "Company") announced that it has discontinued development of fezagepras.
The decision to discontinue the development of fezagepras is...
ZyVersa Therapeutics, Inc., a clinical stage specialty biopharmaceutical company leveraging advanced, proprietary technologies to develop product candidates that address unmet medical needs in the...
Univar Solutions Inc., a leading global solutions provider to users of specialty ingredients and chemicals, announced that NexusBioAg, a division of Univar Solutions, and...
Carl Zeiss Meditec and Precise Bio, a regenerative medicine company advancing the use of bio-printed tissues and organs, announced that the companies have entered...
Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel cancer therapeutics, announced the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation...
